– Financing includes leading U.S. biotechnology institutional investors and mutual funds – LOS ANGELES, CA, May 22, 2026 (GLOBE NEWSWIRE)…
May 07, 2026 19:07 ET | Source: Cue Biopharma, Inc. BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.…
April 19, 2026 19:45 ET | Source: Sutro Biopharma, Inc. STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing…
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that…
– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…
SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has…
March 06, 2026 16:15 ET | Source: Crescent Biopharma, Inc. WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma,…
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…